Editor in Chief:
A. R. Dehpour, PharmD, PhD
A. Javadian, MD
We ask authors and peer-reviewers to submit their articles and reports via our secure online system. There is an online help guide to assist in using this system, and a helpdesk email account for any technical problems.
Editorial decisions are not a matter of counting votes or numerical rank assessments, and we do not always follow the majority recommendation. We try to evaluate the strength of the arguments raised by each reviewer and by the authors, and we may also consider other information not available to either party. Our primary responsibilities are to our readers and to the scientific community at large, and in deciding how best to serve them, we must weigh the claims of each paper against the many others also under consideration.
Reviewers are welcome to recommend a particular course of action, but they should bear in mind that the other reviewers of a particular paper may have different technical expertise and/or views, and the editors may have to make a decision based on conflicting advice. The most useful reports, therefore, provide the editors with the information on which a decision should be based. Setting out the arguments for and against publication is often more helpful to the editors than a direct recommendation one way or the other.
Double blind peer review
Acta Medica Iranica offers a double-blind peer review option. Neither the peer reviewers nor the authors are revealed to each other. Authors may suggest preferred and non-preferred reviewers during manuscript submission. However, the ultimate selection of the reviewers will be determined by the editor(s).
We ask reviewers not to identify themselves to authors while the manuscript is under consideration without the editor's knowledge. If this is not practicable, we ask authors to inform the editor as soon as possible after a reviewer has revealed his or her identity to the author.
Peer review process
The peer-review process is the main mechanism for ensuring the quality of published articles. To this end, the submitted articles are rigorously peer-reviewed to ensure the high quality submissions are accepted and published. The decision to accept a manuscript is not based solely on the scientific validity and originality of the study content; other factors are considered, including the level of innovation, extent and importance of new information in the paper as compared with that in other papers being considered, the Journal's need to represent a wide range of topics, and the overall suitability for Journal. Peer review process is follow as below mention steps:
Editing referees' reports
As a matter of policy, we do not suppress reviewers' reports; any comments that were intended for the authors are transmitted, regardless of what we may think of the content. On rare occasions, we may edit a report to remove offensive language or comments that reveal confidential information about other matters. We ask reviewers to avoid statements that may cause needless offence; conversely, we strongly encourage reviewers to state plainly their opinion of a paper.
Acta Medica Iranica is committed to rapid editorial decisions and publication, and we believe that an efficient editorial process is a valuable service both to our authors and to the scientific community as a whole. We therefore ask reviewers to respond promptly within the number of days agreed. If reviewers anticipate a longer delay than previously expected, we ask them to let us know so that we can keep the authors informed and, where necessary, find alternatives.
|This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.|